ITGR
Integer Holdings Corporation · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 2.21K | $279,897 | n/a | −2 |
| Q2 2026 | 101 | +2 | 28.79M | $2.68B | +9 | −9 |
| Q1 2026 | 104 | -9 | 26.92M | $2.35B | +3 | −12 |
| Q4 2025 | 112 | 0 | 26.76M | $2.10B | +2 | −2 |
| Q3 2025 | 18 | +1 | 15.88M | $1.64B | +2 | −1 |
| Q2 2025 | 14 | -3 | 14.18M | $1.74B | n/a | −3 |
| Q1 2025 | 14 | +3 | 3.90M | $459.91M | +4 | −1 |
| Q4 2024 | 11 | 0 | 3.37M | $446.77M | n/a | n/a |
| Q3 2024 | 10 | 0 | 2.03M | $264.18M | n/a | n/a |
| Q2 2024 | 10 | n/a | 2.05M | $237.56M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 2.21K | -27.3% | $279,897 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Assenagon Asset Management… | $1.49M | was 0.0% |
| Assetmark, Inc | $4,018 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3 holders, 175.00K shares, $206,675 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 11.77K sh · $1.49M
Officer · 19.77K sh · $2.50M
Officer · 9.41K sh · $1.19M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
14.0% of class · View original SEC filing ↗